VARENICLINE

---

Champix (active molecule : Varenicline) Champix is a drug recommended in the framework of tobacco withdrawal (date of authorization of commercialization : September 2006, commercialized in France beginning of 2007). It acts as a partial agonist of nicotinic receptors. Here, conditionning of the beginning of treatment : a week of tablets of 0,5 mg of varenicline (white on blue background) then a week of tablets of 1 mg of varenicline (light blue on green background).

---

Size: 2414px × 3630px
Photo credit: © BELMONTE / BSIP / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: addiction, agonist, agonists, ashtray, ashtrays, cancer-causing, carcinogen, carcinogenic, carcinogens, carcinogous, cessation, champix, cigarette, cigarettes, computer, computerized, computers, dependence, give, giving, keyboard, life, lifes, medical, medicinal, medicine, medicines, nicotine, nicotinic, pack, packet, packets, packs, product, products, quit, quit-smoking, quitting, receptor, receptors, smoking, stop, stopping, tartrate, tobacco, tobaccoism, treatment, tumorigen, tumorigens, tumourigen, tumourigens, varenicline, withdrawl